| A meta‐analysis of SARS‐CoV‐2 patients identifies the combinatorial significance of D‐dimer, C‐reactive protein, lymphocyte, and neutrophil values as a predictor of disease … K Singh, S Mittal, S Gollapudi, A Butzmann, J Kumar, RS Ohgami International journal of laboratory hematology 43 (2), 324-328, 2021 | 78 | 2021 |
| A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease A Butzmann, J Kumar, K Sridhar, S Gollapudi, RS Ohgami Biology 10 (4), 251, 2021 | 28 | 2021 |
| Involvement of microRNA181a in differentiation and cell cycle arrest induced by a plant-derived antioxidant carnosic acid and vitamin D analog doxercalciferol in human leukemia … J Duggal, J S Harrison, G P Studzinski, X Wang MicroRNA 1 (1), 26-33, 2012 | 20 | 2012 |
| Mutations in JAK/STAT and NOTCH1 genes are enriched in post-transplant lymphoproliferative disorders A Butzmann, K Sridhar, D Jangam, H Song, A Singh, J Kumar, ... Frontiers in Oncology 11, 790481, 2022 | 13 | 2022 |
| A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital … A Butzmann, K Sridhar, D Jangam, J Kumar, MK Sahoo, N Shahmarvand, ... International Journal of Molecular Medicine 46 (4), 1466-1476, 2020 | 13 | 2020 |
| Histology-Independent Signature Distinguishes Kikuchi-Fujimoto Disease/Systemic Lupus Erythematosus–Associated Lymphadenitis From Benign and Malignant Lymphadenopathies GD Scott, J Kumar, JS Oak, SD Boyd, PW Raess, DA Gratzinger American journal of clinical pathology 154 (2), 215-224, 2020 | 13 | 2020 |
| Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias S Testa, J Kumar, AJ Goodell, JL Zehnder, KM Alexander, S Sidana, ... Seminars in Oncology 49 (6), 465-475, 2022 | 10 | 2022 |
| Measurement of cell volume using in-line digital holography H Ling, K Sridhar, S Gollapudi, J Kumar, RS Ohgami Microscopy 70 (4), 333-339, 2021 | 8 | 2021 |
| LIM domain only 2 (LMO2) expression distinguishes T‐lymphoblastic leukemia/lymphoma from indolent T‐lymphoblastic proliferations N Brar, A Butzmann, J Kumar, R Peerani, EA Morgan, G Grigoriadis, ... Histopathology 77 (6), 984-988, 2020 | 7 | 2020 |
| Visualizing the prostate gland by MR imaging in young and old mice M Ravoori, J Duggal, M Gagea, L Han, S Singh, P Liu, W Wei, DK Ragan, ... PloS one 8 (3), e55746, 2013 | 7 | 2013 |
| Indolent T‐lymphoblastic proliferation: A systematic review of the literature analyzing the epidemiologic, clinical, and pathologic features of 45 cases A Saglam, K Singh, S Gollapudi, J Kumar, N Brar, A Butzmann, R Warnke, ... International Journal of Laboratory Hematology 44 (4), 700-711, 2022 | 6 | 2022 |
| Hypodiploid B-lymphoblastic leukemia presenting as an isolated orbital mass prior to systemic involvement: a case report and review of the literature L Wang, DC Ashraf, B Kinde, RS Ohgami, J Kumar, RC Kersten Diagnostics 11 (1), 25, 2020 | 6 | 2020 |
| Noninvasive assessment of gene transfer and expression by in vivo functional and morphologic imaging in a rabbit tumor model MK Ravoori, L Han, SP Singh, K Dixon, J Duggal, P Liu, R Uthamanthil, ... PloS one 8 (6), e62371, 2013 | 6 | 2013 |
| Histiocytic Sarcoma With CCND1 Gene Rearrangement Clonally Related and Transdifferentiated From Mantle Cell Lymphoma J Kumar, M Al-Kawaaz, BA Martin, MM Hegazi, B Tan, D Gratzinger American Journal of Clinical Pathology 158 (4), 449-455, 2022 | 5 | 2022 |
| Point Mutation Specific Antibodies in B-Cell and T-Cell Lymphomas and Leukemias: Targeting IDH2, KRAS, BRAF and Other Biomarkers RHOA, IRF8, MYD88, ID3, NRAS, SF3B1 and EZH2 K Singh, S Gollapudi, S Mittal, C Small, J Kumar, RS Ohgami Diagnostics 11 (4), 600, 2021 | 5 | 2021 |
| The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms V Khanna, R Lu, J Kumar, A Molina, H Stehr, E Spiteri, M Spinner, O Silva, ... Leukemia Research 136, 107433, 2024 | 4 | 2024 |
| De Sanctis-Cacchione Syndrome J Kumar Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2020 | 4 | 2020 |
| Case Report: Castleman Disease With an Associated Stromal Spindle Cell Proliferation, PDGFRB Mutation and p53 Expression: Clonal Origins of a Rare Disease KI Singh, S Gollapudi, J Kumar, A Butzmann, C Small, S Kreimer, ... Frontiers in Oncology 12, 857606, 2022 | 3 | 2022 |
| Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies M Krystel-Whittemore, K Petrova-Drus, RN Ptashkin, MD Ewalt, JJ Yao, ... Haematologica 109 (10), 3269, 2024 | 2 | 2024 |
| Acute leukemia with predominantly myeloid differentiation and TBL1XR1::CSF1R fusion J Kumar, K Petrova-Drus Blood 142 (14), 1253-1253, 2023 | 2 | 2023 |